[Melatonin, methadone, tacrine, vitamin K antagonists and low-molecular-weight heparin].
Presentation of three controversial drugs with unequal value and of new anticoagulation strategies. The renewal of interest in oral anticoagulants is striking; it is the consequence of the better measure of the hypocoagulability and a diminution of the risk of haemorrhage. Also as striking, is the extension of the preventive and curative indications of the low molecular weight heparins.
Sternon
J
J
Service de Médecine Interne, Hpital Erasme, Bruxelles.
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D002940:Circadian Rhythm / Q000187:drug effects; D003072:Cognition Disorders / Q000188:drug therapy; D006556:Heroin Dependence / Q000188:drug therapy; D006801:Humans; D008550:Melatonin / Q000494:pharmacology*; D008691:Methadone / Q000627:therapeutic use*; D009294:Narcotics / Q000627:therapeutic use*; D013619:Tacrine / Q000627:therapeutic use*; D014812:Vitamin K / Q000037:antagonists & inhibitors*
D000925:Anticoagulants; D002800:Cholinesterase Inhibitors; D009294:Narcotics; D014812:Vitamin K; D013619:Tacrine; D008550:Melatonin; D008691:Methadone